https://www.selleckchem.com/products/dup-697.html
The findings from this review indicate that ambroxol, for its intended over-the-counter indications, is both efficacious and well tolerated in children and that the favorable benefit/risk profile of ambroxol reported in adults extends to the pediatric population, starting from early infancy, with acute and chronic respiratory diseases. ©Copyright the Author(s), 2020.Introduction In several countries of the world, smartphone applications have been designed to contribute to the treatment of asthma. However, none of these applications has
Like
Comment
Share
